Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Muscarinic Acetylcholine Receptor M2 Antikörper

CHRM2 Reaktivität: Human WB, IF, FACS, Func, IA Wirt: Maus Monoclonal B8E5 unconjugated
Produktnummer ABIN2192224
  • Target Alle Muscarinic Acetylcholine Receptor M2 (CHRM2) Antikörper anzeigen
    Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))
    Reaktivität
    • 89
    • 40
    • 37
    • 8
    • 8
    • 8
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    Human
    Wirt
    • 79
    • 10
    • 2
    • 1
    Maus
    Klonalität
    • 79
    • 13
    Monoklonal
    Konjugat
    • 44
    • 5
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Dieser Muscarinic Acetylcholine Receptor M2 Antikörper ist unkonjugiert
    Applikation
    • 78
    • 34
    • 26
    • 26
    • 19
    • 18
    • 15
    • 11
    • 8
    • 6
    • 4
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Functional Studies (Func), Immunoassay (IA)
    Sterilität
    0.2 μm filtered
    Klon
    B8E5
    Top Product
    Discover our top product CHRM2 Primärantikörper
  • Applikationshinweise
    It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS, containing 0.1 % bovine serum albumin.
    Lagerung
    4 °C
  • Nascimento, Sallé, Hoebeke, Argibay, Peineau: "cGMP-mediated inhibition of cardiac L-type Ca(2+) current by a monoclonal antibody against the M(2) ACh receptor." in: American journal of physiology. Cell physiology, Vol. 281, Issue 4, pp. C1251-8, (2001) (PubMed).

    Elies, Fu, Eftekhari, Wallukat, Schulze, Granier, Hjalmarson, Hoebeke: "Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor." in: European journal of biochemistry / FEBS, Vol. 251, Issue 3, pp. 659-66, (1998) (PubMed).

  • Target
    Muscarinic Acetylcholine Receptor M2 (CHRM2) (Cholinergic Receptor, Muscarinic 2 (CHRM2))
    Andere Bezeichnung
    Muscarinic Acetylcholine Receptor m2 (CHRM2 Produkte)
    Synonyme
    HM2 antikoerper, AChR-M2 antikoerper, Chrm-2 antikoerper, M2 antikoerper, chrm2 antikoerper, Acm2 antikoerper, GPM2 antikoerper, cholinergic receptor muscarinic 2 antikoerper, cholinergic receptor, muscarinic 2, cardiac antikoerper, cholinergic receptor, muscarinic 2a antikoerper, cholinergic receptor, muscarinic 2 antikoerper, CHRM2 antikoerper, Chrm2 antikoerper, chrm2a antikoerper
    Hintergrund
    The monoclonal antibody B8E5 recognizes human muscarinic acetylcholine receptor M2 (M2 receptor), a G protein-coupled cardiovascular receptor of ~55 kDa. This receptor is an integral membrane protein consisting of seven membrane spanning α-helices linked together by extra- and intracellular loops that form a pharmacophore pocket. Autoantibodies directed against cardiovascular G protein-coupled receptors functionally interfering with the target have been described in several cardiovascular diseases. The M2 receptor is the predominant sybtype of muscarinic receptors present in the heart of mammalian species. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is adenylate cyclase inhibition. 2+ Monoclonal antibody B8E5 inhibits the ß-adrenergic L-type Ca currents through activation of the muscarinic acetylcholine receptor M2. It suggests that the antibody acts not via the classical pathway of decreasing cAMP, but rather by increasing cGMP. Monoclonal antibody B8E5 acts by functional dimerization of the receptor resulting in stabilization of the constitutive active receptor dimers and paradoxically induces a small decrease in carbachol affinity for the M2 receptor. It recognizes the pentapeptide VRTVE (aa 168-172) corresponding to the N-terminal part of the second extracellular loop of the human M2 receptor. M2ACh-R Aliases Peptide VRTVEDGECYIQFFSNAAVTFGTAI(C): Human second extracellular loop residues 168-192 Immunogen Mouse IgG2a
Sie sind hier:
Kundenservice